Gilead Sciences Inc (GILD)

Exchange
NASDAQ
Symbol
GILD
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    97.03
  • High
    99.45
  • Low
    96.74
  • Close
    98.38
  • Volume
    10,515,600

Financial ratios

Dec 31, 2023